Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.
about
'Acute myeloid leukemia: a comprehensive review and 2016 update'Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia.Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigenComparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionAllogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.Molecular diagnostics in acute leukemias.Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia.Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.Twenty years of experience on stem cell transplantation in iran.Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.Interactive diagnostics in the indication to allogeneic SCT in AML.Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation.Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification.Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations.Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.Unfavorable-risk cytogenetics in acute myeloid leukemia.Upfront therapy of acute myeloid leukemia.Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia.Acute myeloid leukemia with normal cytogenetics.Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensusAllogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.Frontline treatment of acute myeloid leukemia in adults.Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8.Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.Outcomes of allogeneic stem cell transplantation among patients with acute myeloid leukemia presenting active disease: Experience of a single European Comprehensive Cancer Center.Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia.Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision
P2860
Q28072539-6BD60359-87F1-4960-A692-9AAD2107FA8AQ31052875-7368EEAE-4E9A-4D40-9E6C-3D02EE4893B3Q33611146-584B3845-54BF-4F3C-B4D3-F370D4D5BC45Q34243434-9B1615D7-1DE0-4FA1-83C0-DD4A1A23DF6DQ34401926-E6E1863E-9DF4-4F26-AE1C-618F8A0480EAQ34608688-86D2EEE6-FC6F-4F37-800D-4B33CBA2E07AQ34620456-B04094B4-B2B9-4F49-9725-910343BE10B7Q34630588-737A39EF-EC87-4E38-8F5B-84727B416191Q34877613-155D9838-53CA-477A-A52D-D52DAAFCF238Q35007333-865562A1-CD24-48A1-9916-919AB29F46C6Q35800814-6E03B709-F475-4F30-AD5B-FCEA30E11990Q35953348-8ED466B7-7B24-42D0-8C35-0F64E94FD7F9Q36006412-CD29C5EC-2CDE-43E1-B8B1-21D9002F3D84Q36839332-723F1BB5-A89F-4EBF-90E0-040D04DA0FD1Q37061969-E8411872-1C6D-4CA4-AA9A-AE73D1DEF872Q37118840-313E0F6C-5160-4A2C-BC1C-8C962C19ECA2Q37249351-EFD1D0B1-97CC-42DA-9C4E-FC511757981DQ37323006-63D14DCB-AA3A-4B11-8F19-6CC59E8CEF8DQ37362603-33F4D0DC-E3DB-4674-8827-F304EBD73F88Q37442649-ECB1E699-7AC6-415F-A669-774A16407C68Q37486793-A0C1D231-4161-4C00-852A-CB7E8D0139FFQ37559330-586470C4-F5B7-40FC-BA26-7387FD7498A1Q37842488-2634D8BC-1C8B-4333-8A56-C02FB95E1EE3Q37842861-4AB4969C-2A65-46D0-8EC7-EE6F52A0A67AQ37865545-8738A837-2714-4B52-90E5-731FBA82B769Q37897183-3D10940C-E232-448E-BFE8-0B8FBDF07D32Q38015268-466F7057-3455-435D-8E48-2D1F5D1C5CA1Q38027047-42059F40-CCBB-4ADD-B4F5-7E4E27A8270CQ38106983-F0888A52-E9B5-4FF2-BE8E-EA6E0B78CA65Q38248427-A9546BBF-5AA3-4455-AB3C-9D4DB6F1430CQ38767583-4EA379ED-27BB-4D64-A498-6D6301CC585CQ39036994-6AED2DA4-14B7-4481-A276-1BCEBB40FDCAQ39805868-98562754-F418-4AE6-9523-9EF0DF867707Q40183293-033A20A0-FF32-434D-8D73-35054CFB5B23Q40199108-488F0BA2-C8FF-46B5-8763-4AA6D22B33E5Q40438036-EEBBE95A-5825-4034-BA7A-2EAB55CCEE4EQ41092916-DCA4D6B7-E2BF-470D-85FE-60DD145A0684Q41539854-ADF06EF6-0417-4D34-93C9-BAD718FB1262Q41607636-0B04CABD-29A9-4A80-A95E-89581390C35BQ41879404-A3E76ABF-ED74-4F54-9FFE-874E675B5C67
P2860
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@ast
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@en
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@nl
type
label
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@ast
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@en
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@nl
prefLabel
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@ast
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@en
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@nl
P2093
P356
P1433
P1476
Efficacy of allogeneic hematop ...... ase remission: a metaanalysis.
@en
P2093
Masamitsu Yanada
Nobuhiko Emi
Tomoki Naoe
P304
P356
10.1002/CNCR.20945
P407
P577
2005-04-01T00:00:00Z